Extracellular vesicle-mediated VEGF-A mRNA delivery rescues ischaemic injury with low immunogenicity
AbstractBackground and Aims. Lackluster results from recently completed gene therapy clinical trials of VEGF-A delivered by viral vectors have heightened t